Phreesia, Inc.

NYSE:PHR

24.05 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 102.115101.21795.00591.61985.8383.84576.58673.10367.86763.35458.0255.91551.00748.29141.80838.46435.00933.39632.81532.84330.81628.3126.48324.75624.77923.871
Cost of Revenue 40.30640.88540.22830.93930.30130.99727.96427.33227.42726.54422.35621.09319.6818.25914.78414.00212.01811.58211.17311.2911.31110.94510.0569.1988.938.813
Gross Profit 61.80960.33254.77760.6855.52952.84848.62245.77140.4436.8135.66434.82231.32730.03227.02424.46222.99121.81421.64221.55319.50517.36516.42715.55815.84915.058
Gross Profit Ratio 0.6050.5960.5770.6620.6470.630.6350.6260.5960.5810.6150.6230.6140.6220.6460.6360.6570.6530.660.6560.6330.6130.620.6280.640.631
Reseach & Development Expenses 29.54228.88129.86228.54427.47126.46925.39822.66922.54220.63517.49515.27311.4438.0546.3555.7325.535.0054.864.7744.694.2994.2053.8563.1793.109
General & Administrative Expenses 19.49719.05218.82120.2420.98819.87719.85619.620.07320.85521.73818.02116.24412.67111.73910.379.6318.729.6097.1847.426.2455.9584.544.654.928
Selling & Marketing Expenses 30.18432.01135.87336.47837.24437.41336.2636.63138.34140.03137.20632.03622.16715.01212.95910.48110.0989.4348.1878.3488.127.7026.3967.1956.5296.247
SG&A 49.48950.87154.50256.71858.23257.2956.11656.23158.41460.88658.94450.05738.41127.68324.69820.85119.72918.15417.79615.53215.5413.94612.35311.73511.17811.175
Other Expenses -0.086-0.0310.083-0.0470.056.996.9216.6825.8195.8820.06-0.114-0.090.0660.230.0620.424-0.715-0.2830.0770.327-1.145-0.1740.2030.139-0.175
Operating Expenses 79.03179.75284.36492.72592.48490.74988.43585.58286.77587.40382.2870.56255.13540.68535.30530.57629.30126.7826.31423.78423.64621.61919.72518.59417.09716.968
Operating Income -17.222-19.42-29.587-32.045-36.955-37.901-39.813-39.811-46.335-50.593-46.616-35.74-23.808-10.653-8.281-6.114-6.31-4.966-4.672-2.231-4.14-4.255-3.299-3.036-1.249-1.91
Operating Income Ratio -0.169-0.192-0.311-0.35-0.431-0.452-0.52-0.545-0.683-0.799-0.803-0.639-0.467-0.221-0.198-0.159-0.18-0.149-0.142-0.068-0.134-0.15-0.125-0.123-0.05-0.08
Total Other Income Expenses Net -0.040.208-0.842-0.0470.050.6761.621-0.15-0.168-0.4140.06-0.114-0.090.0660.230.0620.424-0.715-0.2830.077-2.556-1.568-0.735-0.408-0.454-0.466
Income Before Tax -17.262-19.212-30.429-31.569-36.119-37.225-38.192-39.961-46.503-51.007-46.884-36.165-24.105-10.825-8.418-6.519-6.305-6.001-5.631-2.373-7.442-6.627-5.079-4.172-2.587-3.224
Income Before Tax Ratio -0.169-0.19-0.32-0.345-0.421-0.444-0.499-0.547-0.685-0.805-0.808-0.647-0.473-0.224-0.201-0.169-0.18-0.18-0.172-0.072-0.241-0.234-0.192-0.169-0.104-0.135
Income Tax Expense 0.750.510.2170.3720.6480.306-0.1710.2060.2130.235-0.4330.1780.2880.149-0.3220.1940.0660.111-1.9630.0640.0510.0681.6071.341.4771.139
Net Income -18.012-19.722-30.646-31.941-36.767-37.531-38.021-40.167-46.716-51.242-46.451-36.343-24.393-10.974-8.096-6.713-6.371-6.112-3.668-2.437-7.493-6.695-5.079-4.172-2.587-3.224
Net Income Ratio -0.176-0.195-0.323-0.349-0.428-0.448-0.496-0.549-0.688-0.809-0.801-0.65-0.478-0.227-0.194-0.175-0.182-0.183-0.112-0.074-0.243-0.236-0.192-0.169-0.104-0.135
EPS -0.31-0.35-0.56-0.58-0.68-0.7-0.72-0.76-0.89-0.99-0.93-0.71-0.48-0.24-0.18-0.17-0.17-0.16-0.1-0.068-1.1-0.19-0.18-0.15-0.092-0.11
EPS Diluted -0.31-0.35-0.56-0.58-0.68-0.7-0.72-0.76-0.89-0.99-0.9-0.71-0.48-0.24-0.18-0.17-0.17-0.16-0.1-0.068-1.1-0.19-0.18-0.15-0.092-0.11
EBITDA -9.727-12.555-21.133-24.582-30.174-30.911-32.892-33.129-40.516-44.711-40.775-30.508-18.527-5.705-4.029-2.121-2.268-1.345-1.0141.2472.159-0.4570.430.5782.0841.066
EBITDA Ratio -0.095-0.124-0.222-0.268-0.352-0.369-0.429-0.453-0.597-0.706-0.703-0.546-0.363-0.118-0.096-0.055-0.065-0.04-0.0310.0380.07-0.0160.0160.0230.0840.045